The forecasted share of corresponding/leading authors in scientific publications in applied microbiology and biotechnology in China shows a steady increase from 2024 to 2028, with a value starting at 98.76% in 2024 and reaching 98.84% in 2028. The year-on-year growth is minimal, indicating a stable but gradually increasing trend. As of the end of 2023, historical data are unavailable; however, these forecasts suggest an entrenched dominance of corresponding/leading authors in these publications.
- The expected Compound Annual Growth Rate (CAGR) over the next five years is extremely slight, reflecting the ongoing strong contribution by leading authors.
Future trends to watch for include improved collaborations and possible shifts in publishing dynamics due to evolving policy changes, technological advancements, or incentives that could either consolidate or diversify authorship patterns further, especially with China's strategic focus on scientific advancements and innovation.
